Related Experiment Video
Updated: Jun 26, 2025
06:23
Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
8.0K
Research progress in Alzheimer's disease and bone-brain axis
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Ageing Research Reviews
|May 17, 2024
Summary
Alzheimer's disease (AD) is linked to orthopedic conditions like osteoporosis. Understanding the bone-brain axis offers new pathways for AD diagnosis and treatment.
Area of Science:
- Neuroscience
- Orthopedics
- Gerontology
Background:
- Alzheimer's disease (AD) is a leading cause of cognitive impairment.
- AD shares epidemiological and pathogenic links with orthopedic diseases, including osteoporosis and osteoarthritis.
- The bone-brain axis represents a bidirectional communication pathway between skeletal and neural tissues.
Purpose of the Study:
- To review current research on the relationship between AD and orthopedic diseases.
- To explore the mechanisms of the bone-brain axis in AD pathogenesis.
- To discuss therapeutic strategies targeting the bone-brain axis for AD.
Main Methods:
- Literature review of existing research on Alzheimer's disease and orthopedic conditions.
- Analysis of studies investigating the bone-brain axis.
- Synthesis of information on therapeutic targets within the bone-brain axis.
Main Results:
- The review highlights significant connections between AD and orthopedic diseases.
- Evidence supports the role of the bone-brain axis in AD development.
- Targeting the bone-brain axis presents potential for novel AD therapies.
Conclusions:
- The bone-brain axis is a crucial factor in understanding AD.
- Further research into bone-brain communication can aid early AD diagnosis.
- Modulating the bone-brain axis may lead to innovative treatments for Alzheimer's disease.
Related Concept Videos
01:26Alzheimer's Disease: Overview
467
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
467
01:22Alzheimer's Disease: Treatment
181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K